Analyzing the demographics of patients with uveitis in an indigent, urban population
- PMID: 37020208
- PMCID: PMC10077706
- DOI: 10.1186/s12886-023-02888-3
Analyzing the demographics of patients with uveitis in an indigent, urban population
Abstract
Purpose: To study the types of uveitis examined in a hospital serving indigent populations in need of low-cost care.
Methods: A retrospective chart review examined the electronic medical records of all patients with uveitis-related at Drexel Eye Physicians. Data collected included demographics, anatomic location of the uveitis, systemic disease associations, treatment modalities and insurance. Statistical analysis was performed using χ² or Fischer exact tests.
Results: 270 patients (366 eyes) were included for analysis, 67% of patients identified as African American. Most eyes (95.3%, N = 349) were treated with topical corticosteroid drops, and only 6 (1.6%) received an intravitreal implant. Immunosuppressive medications were started in 24 patients (8.9%). Nearly 80% depended to some extent on Medicare or Medicaid Assistance for treatment coverage. There was no association between insurance type and use of biologics or difluprednate.
Conclusion: We found no association between insurance type and the prescription of medications for uveitis that should be used at home. There was a minimal number of patients prescribed medications for implantation in the office. The adherence of use of medications at home should be investigated.
Keywords: Indigent; Low-cost care; Philadelphia; Uveitis.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids.Ophthalmology. 2020 Apr;127(4S):S21-S26. doi: 10.1016/j.ophtha.2020.01.036. Ophthalmology. 2020. PMID: 32200821
-
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.J Ocul Pharmacol Ther. 2013 Jun;29(5):501-7. doi: 10.1089/jop.2012.0180. Epub 2013 Jan 8. J Ocul Pharmacol Ther. 2013. PMID: 23297752
-
Prescription coverage in indigent patients affects the use of long-acting opioids in the management of cancer pain.Pain Med. 2014 Jan;15(1):42-51. doi: 10.1111/pme.12238. Epub 2013 Sep 23. Pain Med. 2014. PMID: 24106748 Free PMC article.
-
New developments in corticosteroid therapy for uveitis.Ophthalmologica. 2010;224 Suppl 1:46-53. doi: 10.1159/000318021. Epub 2010 Aug 18. Ophthalmologica. 2010. PMID: 20714181 Review.
-
Local therapy for cancer therapy-associated uveitis: a case series and review of the literature.Br J Ophthalmol. 2020 May;104(5):703-711. doi: 10.1136/bjophthalmol-2019-314403. Epub 2019 Aug 13. Br J Ophthalmol. 2020. PMID: 31409649 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical